Dxcover Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
23
Dxcover General Information
Description
Developer of a liquid biopsy platform designed to detect cancer. The company utilizes infrared spectroscopy, multi-omic spectral analysis, recurrent neural networks, automated sample handling, generative data augmentation, and slide-based hardware, enabling healthcare providers to identify disease-specific signatures from blood samples for rapid clinical triage.
Contact Information
Website
www.dxcover.comCorporate Office
- 5 Robroyston Oval
- Nova Technology Park
- Glasgow G33 1AP
- Scotland, United Kingdom
Corporate Office
- 5 Robroyston Oval
- Nova Technology Park
- Glasgow G33 1AP
- Scotland, United Kingdom
Dxcover Timeline
Dxcover Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Accelerator/Incubator | 31-Mar-2026 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 24-Jan-2025 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series 3) | 23-Jan-2023 | Completed | Generating Revenue | |||
| 8. Grant | 05-Oct-2022 | Completed | Clinical Trials - General | |||
| 7. Later Stage VC | 04-Mar-2021 | Completed | Clinical Trials - General | |||
| 6. Grant | 01-Jun-2019 | $332K | $1.64M | Completed | Clinical Trials - General | |
| 5. Seed Round | 28-Mar-2019 | $1.64M | $1.64M | Completed | Clinical Trials - General |
Dxcover Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A1 Ordinary | ||||||||
| A Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 3,278,464 | $0.001237 | $1.32 | $1.32 | 1x | $1.32 | 21.69% | |
| Ordinary | 1,723,576 | $0.001237 | $0.89 | $0.89 | 1x | $0.89 | 11.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Dxcover Comparisons
Industry
Financing
Details
Dxcover Competitors (16)
One of Dxcover’s 16 competitors is Lunaphore, a Formerly VC-backed company based in Tolochenaz, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lunaphore | Formerly VC-backed | Tolochenaz, Switzerland | ||||
| Exosomics | Venture Capital-Backed | Siena, Italy | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Asuragen | Formerly VC-backed | Austin, TX | ||||
| Epic Sciences | Venture Capital-Backed | San Diego, CA |
Dxcover Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Dxcover Patents
Dxcover Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202503522-D0 | Control test for spectroscopic measurement | Pending | 06-Feb-2025 | ||
| GB-2705587-A | Control test for spectroscopic measurement | Pending | 06-Feb-2025 | ||
| WO-2026167340-A1 | Control test for spectroscopic measurement | Pending | 06-Feb-2025 | ||
| EP-4695599-A1 | Colorectal cancer detection | Pending | 12-Apr-2023 | ||
| GB-202305326-D0 | Colorectal cancer detection | Inactive | 12-Apr-2023 | G01N21/552 |
Dxcover Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dxcover Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MassBio | Accelerator/Incubator | |||
| SCbio | Accelerator/Incubator | |||
| The NHS Innovation Accelerator | Accelerator/Incubator | |||
| Campbell Johnston Clark | Corporation | Minority | ||
| Macmillan Cancer Support | Not-For-Profit Venture Capital | Minority |
Dxcover FAQs
-
When was Dxcover founded?
Dxcover was founded in 2016.
-
Where is Dxcover headquartered?
Dxcover is headquartered in Glasgow, United Kingdom.
-
What is the size of Dxcover?
Dxcover has 31 total employees.
-
What industry is Dxcover in?
Dxcover’s primary industry is Diagnostic Equipment.
-
Is Dxcover a private or public company?
Dxcover is a Private company.
-
What is Dxcover’s current revenue?
The current revenue for Dxcover is .
-
How much funding has Dxcover raised over time?
Dxcover has raised $21.8M.
-
Who are Dxcover’s investors?
MassBio, SCbio, The NHS Innovation Accelerator, Campbell Johnston Clark, and Macmillan Cancer Support are 5 of 23 investors who have invested in Dxcover.
-
Who are Dxcover’s competitors?
Lunaphore, Exosomics, Illumina, Asuragen, and Epic Sciences are some of the 16 competitors of Dxcover.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
